Financing

[Market In] Far Exceeding the Target Amount by 10 Times… 2.1 Trillion Won in “Lump-Sum Funds” Flows into NH INVESTMENT & SECURITIES Corporate Bonds

NH INVESTMENT & SECURITIES to Conduct Bookbuilding for 200 Billion Won in Corporate Bonds on the 8th Buy Orders Totaling 2.19 Trillion Flood In for 2-, 3-, and 5-Year Bonds Proven Success as All Tranches Achieve Negative (-) Interest Rates

LEE GEON-EOM
2026-09-08 18:00:03
[Edaily Marketin LEE GEON-EOM Reporter] NH INVESTMENT & SECURITIES(005940)The company successfully secured its target issuance amount by raising funds exceeding 10 times the target amount during the bookbuilding process for its corporate bonds.
Exterior of NH INVESTMENT & SECURITIES. (Photo courtesy of NH INVESTMENT & SECURITIES)

According to the financial investment industry on the 8th, NH INVESTMENT & SECURITIES received 2.19 trillion won in orders during the bookbuilding for its unsecured corporate bonds totaling 200 billion won. Shinhan Investment & Securities, SamsungSecurities, Hana Securities, and DaishinSecurities served as the lead underwriters for the bookbuilding.

By maturity, the 2-year bond, which aimed to raise 50 billion won, received 670 billion won in buy orders. The 3-year bond, targeting 120 billion won, attracted 1.18 trillion won, while the 5-year bond, seeking 30 billion won, drew 340 billion won.

With demand far exceeding the target amount, the issuance rates were set at favorable levels. The spread over the benchmark rate is estimated at minus (-) 6 basis points (1 bp = 0.01 percentage point) for the 2-year bond, minus (-) 6 basis points for the 3-year bond, and minus (-) 3 basis points for the 5-year bond.

Economy

Corporation

IT·Science

Economy

[Market In] IMM PE Launches 800 billion refinancing… Hanssem Faces Test of ‘Valuation Recovery’

IMM Private Equity (IMM PE), a domestic private equity fund (PEF) manager, has begun taking steps to buy time to exit its investment in Hanssem. With acquisition financing totaling around 800 billion …
2026-09-08 18:27:04

Corporation

Neopharm CO., LTD., on a "Record-Breaking Streak of Earnings," Expands into a Global Derma-Beauty Brand

Neopharm CO., LTD.(092730), a South Korean derma-beauty specialist, is seeking to expand into a global derma-beauty brand by leveraging “Atopam,” a skincare brand specializing in sensitive skin condit…
2026-09-08 17:48:06

IT·Science

“Korea’s 44th Domestically Developed New Drug,” Latica, Launched… Taking on the 500 Billion Won Dry Eye Market

(Graphic: ChatGPT) A domestically developed treatment with a new mechanism of action is set to enter the Korean dry eye market, which has long been dominated by artificial tears. This follows the …
2026-09-08 17:11:02